Choudhery et al (2013) Curr Stem Cell Res Ther 8(5): 370-80
Harris (2008) Stem Cell Rev 4:269-274
Beatty PG, Boucher KM, Mori M, Milford EL. Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors. Hum Immunol. 2000;61(8):834-840.
Nature Biotechnology. Hemacord approval may foreshadow regulatory creep for HSC therapies, April 10, 2012.
Copeland EA., MD. Hematopoietic Stem-Cell Transplantation. N Engl J Med 2006;354:1813-1826.
Broxmeyer HE. Cord blood hematopoietic stem cell transplantation. (May 26, 2010), StemBook, ed. The Stem Cell Research Community, StemBook, https://www.stembook.org/node/693.
Nietfeld JJ et al. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant 2008;14:316-22.
McDonald S.J., Middleton P: “Effects of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes.” Cochrane Database of Systematic Reviews. 2011. Issue1.
Rocha V, Wagner JE Jr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee
Pazdur R, Coia L, Hoskins W, et al. Cancer management: a multidisciplinary approach. 1998. Second edition.
Behzad-Behbahani A, Pouransari R, Tabei SZ, et al. Risk of viral transmission via bone marrow progenitor cells versus umbilical cord blood hematopoietic stem cells in bone marrow transplantation. Transplant Proc. 2005;37(7):3211-3212.
Aldenhoven and Kurtzberg, Cytotherapy 2015; 17:765-774 Cord blood is the optimal graft source for the treatment of pediatric patients with lysosomal storage diseases: clinical outcomes and future directions.